BIOMAT Database Logo BIOMAT Database Logo

Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. 1977

P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007223 Infant A child between 1 and 23 months of age. Infants
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Haemophilus influenzae type b polysaccharide vaccines.
September 1985, The Journal of pediatrics,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
[Polysaccharide vaccines against Haemophilus influenzae type B].
January 1994, Przeglad epidemiologiczny,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
February 1993, Current opinion in pediatrics,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Haemophilus influenzae type b vaccines.
January 1992, British journal of hospital medicine,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
[Haemophilus influenzae type b vaccines].
November 1989, Ugeskrift for laeger,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
June 1991, Vaccine,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Haemophilus influenzae type b polysaccharide vaccine.
September 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Haemophilus influenzae type b polysaccharide vaccine.
June 1986, Pediatric annals,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Haemophilus influenzae type b polysaccharide vaccine.
January 1986, MCN. The American journal of maternal child nursing,
P H Mäkelä, and H Peltola, and H Käyhty, and H Jousimies, and O Pettay, and E Ruoslahti, and A Sivonen, and O V Renkonen
Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
April 1996, Vaccine,
Copied contents to your clipboard!